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        Introduction 
  Cell migration is essential to processes such as embryonic 
development and wound healing but also drives the pathology 
of diseases such as cancer. Indeed, one of the features of malig-
nant cells, and one that makes cancer so diffi  cult to treat, is their 
capacity to migrate invasively through the stroma to form me-
tastases (  Sahai, 2005  ). Cell migration can be random or persis-
tent. In 2D, on stiff substrates, cells tend to adopt a polar form 
with a leading lamellipodium, whereas in 3D they can assume 
elongated or amoeboid morphologies (  Sahai, 2005  ). A cell  ’  s 
ability to switch between these migrational modes is likely dic-
tated by the way in which it interacts with and responds to the 
surrounding ECM. Integrins are heterodimeric transmembrane 
receptors that physically link the ECM to the intracellular actin 
cytoskeleton but are also signaling molecules that transduce 
signals bidirectionally across the plasma membrane (  Hynes, 
2002  ). The signaling capacity of certain integrin heterodimers 
has been linked with particular modes of cell migration. For ex-
ample, a study on epithelial cells has concluded that activation 
of Rac downstream of    v  3  integrin  promotes  slow/persistent 
migration, whereas engagement of    5   1 that acts via RhoA-
ROCK signaling drives rapid/random cell movement (  Danen 
et al., 2005  ). 
  Osteopontin is a secreted matrix molecule that becomes 
incorporated into mineralized bone matrix and a ligand for sev-
eral cell surface receptors including CD44 and    v  3  integrin 
(  Rangaswami et al., 2006  ). Increased secretion of osteopontin is 
associated with a range of malignancies and correlates strongly 
with tumor progression and metastasis (  Rittling and Chambers, 
2004  ;   Khodavirdi et al., 2006  ). Some tumors secrete large quan-
tities of soluble osteopontin, which does not become incorpo-
rated into immobile ECM and is, therefore, unlikely to mediate 
adhesive interactions between cells and the matrix (  Rittling 
et al., 2002  ). Nevertheless, osteopontin promotes chemotactic 
cell migration of several cancer cell lines (  Tuck et al., 1999  ). 
H
ere we show that blocking the adhesive function 
of     v    3 integrin with soluble RGD ligands, such 
as osteopontin or cilengitide, promoted associa-
tion of Rab-coupling protein (RCP) with     5    1 integrin and 
drove RCP-dependent recycling of     5    1 to the plasma 
membrane and its mobilization to dynamic rufﬂ  ing protru-
sions at the cell front. These RCP-driven changes in     5    1 
trafﬁ  cking led to acquisition of rapid/random movement 
on two-dimensional substrates and to a marked increase in 
ﬁ  bronectin-dependent migration of tumor cells into three-
dimensional matrices. Recycling of     5    1 integrin did not 
affect its regulation or ability to form adhesive bonds 
with substrate ﬁ  bronectin. Instead,     5    1 controlled the 
association of EGFR1 with RCP to promote the coordinate 
recycling of these two receptors. This modiﬁ  ed signaling 
downstream of EGFR1 to increase its autophosphory  lation 
and activation of the proinvasive kinase PKB/Akt. We con-
clude that RCP provides a scaffold that promotes the phys-
ical association and coordinate trafﬁ  cking of     5    1 and 
EGFR1 and that this drives migration of tumor cells into 
three-dimensional matrices.
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ovarian cancer cells was similar to fi  broblasts, with 25  –  30% of 
internalized integrin returned to the plasma membrane within 
15 min (  Fig. 1 A  , left). However, in cells challenged with either 
cilengitide (a cyclic RGD peptide known to bind to and inhibit 
   v  3  and    v   5), cRGDfV (a cyclic peptide with selectivity 
for    v  3  over    v   5 integrin;   Dechantsreiter et al., 1999  ), or the 
soluble    v   3 ligand osteopontin,    5   1 recycling increased by 
at least twofold, whereas a control cyclic peptide (cRADfV) was 
ineffective in this regard (  Fig. 1 A  , left). Consistent with this, 
suppression of     3 levels by RNAi (Fig. S1, available at avail-
able at http://www.jcb.org/cgi/content/full/jcb.200804140/DC1) 
increased    5   1 recycling, and treatment of    3  knockdown  cells 
with either cilengitide or osteopontin did not further enhance 
   5  1  traffi  cking (  Fig. 1 A  , right). Cilengitide did not affect the 
rate at which    5   1 was internalized by A2780 cells (Fig. S1 B). 
As cilengitide-driven    5   1 recycling was Rab11 dependent 
(Fig. S2 A), these data indicate that    v  3  functions  constitu-
tively to restrain    5   1 recycling in A2780 ovarian cancer cells 
and that removal of    v   3 or its occupation/blockade with soluble, 
non-ECM ligands such as osteopontin or cilengitide releases 
this constraint to drive Rab11-dependent traffi  cking of    5  1  to 
the plasma membrane. 
  Inhibition of     v    3 drives     5    1 and RCP into 
a coprecipitable complex 
 Because physical associations may be formed between Rab effec-
tors and their cargoes (  Fan et al., 2004  ), we immunoprecipitated 
members of the class I family of Rab11 effectors from A2780 
cells and probed for the presence of    5  1  and    v  3  integrins. 
This revealed that RCP associated with both    5  1  and    v  3  in-
tegrins (  Fig. 1 B  ) and pretreatment of the cells with cilengitide 
(  Fig. 1, B and D  ) or osteopontin (  Fig. 1 D  ) strongly promoted 
coprecipitation of RCP with    5   1 but reduced its association 
with    v   3 (  Fig. 1 B  ). Increased association of    5  1  and  RCP 
was detectable within 8 min and was maximal after 20-min 
exposure to cilengitide (Fig. S3 A, available at http://www.jcb
.org/cgi/content/full/jcb.200804140/DC1). To further confi  rm 
these associations, we immunoprecipitated    5  1  and    v  3 
using antibodies recognizing    5  and    3  integrin,  respectively. 
Western blots of these immunoprecipitates indicated that both 
endogenous and overexpressed RCP coprecipitated with    5  1 
and    v   3 (but not with a control antibody) and that addition 
of cilengitide strongly promoted RCP  ’  s association with    5  1, 
but correspondingly weakened binding to    v  3  ( Fig.  1  C ).  Sup-
pression of     3 expression by RNAi also increased association 
between RCP and   5  1, and treatment of   3 knockdown cells with 
cilengitide or osteopontin did not further enhance this (  Fig. 1 D  ). 
Furthermore, RCP 
621E  , containing a point mutation within the 
RBD of RCP rendering it unable to interact with Rab11 (and 
therefore to be considered a dominant-negative inhibitor of RCP 
function), did not associate with    5   1 (  Fig. 1 E  ), indicating that 
Rab11 likely contributes to    5  1 – RCP  complex  formation. 
  RCP regulates integrin recycling and     5    1-
dependent cell movement 
  Although cilengitide promoted    5   1 recycling in cells expressing 
control RNAi or those overexpressing RCP 
wt  , it was completely 
Although it has been shown that osteopontin-driven migration 
may involve modulation of EGF receptor and c-Src signaling 
(  Tuck et al., 2003  ;   Das et al., 2004  ), the relationship between 
the binding of osteopontin to     v integrins and the acquisition of 
tumor cell invasive capacity is not known. 
  Surface integrins are continuously endocytosed, and then 
effi  ciently returned (or recycled) back to the plasma membrane 
(  Caswell and Norman, 2006  ;   Jones et al., 2006  ;   Pellinen and 
Ivaska, 2006  ). The way in which integrins are recycled dictates 
the migrational mode of fi  broblasts, and this is largely owing 
to the infl  uence of recycling pathways on    5  1  ( White  et  al., 
2007  ). Small GTPases of the Rab11 family, including Rab11a 
and Rab25, control recycling of internalized    5  1  ( Roberts  et  al., 
2001  ;   Caswell et al., 2007  ), and this is likely to require the con-
tribution of at least one Rab11 effector protein. The Rab11 family 
of interacting proteins (Rab11-FIPs) bind to GTP-bound Rab11s 
and have been shown to be effectors of Rab11 (  Hales et al., 2001  ; 
  Lindsay et al., 2002  ;   Lindsay and McCaffrey, 2002  ;   Wallace 
et al., 2002  ;   Prekeris, 2003  ;   Peden et al., 2004  ;   Horgan et al., 
2007  ), thus making them potential candidates for components 
of protein complexes that control    5  1  recycling.  The  Rab11-
FIPs share a highly homologous C-terminal Rab11-binding do-
main (RBD) and are categorized into two subfamilies according 
to their domain structures (  Wallace et al., 2002  ;   Prekeris, 2003  ). 
The three identifi  ed class I FIPs (Rab-coupling protein [RCP; 
aka Rab11-FIP1], Rab11-FIP2, and Rab11-interacting protein 
[Rip11; aka pp75 and Rab11-FIP5]) possess an N-terminal phos-
phatidic acid/phosphatidylinositol 3,4,5-trisphosphate  –  binding 
C2 domain (  Lindsay and McCaffrey, 2004a  ), whereas the two 
class II FIPs (Rab11-FIP3 and Rab11-FIP4) can bind to Arf6 as 
well as Rab11s and are thus considered to be effectors for both 
these classes of GTPase (  Hickson et al., 2003  ;   Horgan et al., 
2004  ). It is now becoming clear that Rab11-regulated processes 
can be linked to cancer (  Goldenring et al., 1999  ). Indeed, Rab25 
contributes to the aggressiveness of breast and ovarian cancers 
(  Cheng et al., 2004  ) and likely achieves this in part by altering 
the traffi  cking of    5   1 to promote invasive migration (  Caswell 
et al., 2007  ). Furthermore, Rab11 controls recycling of    6  4 
integrin in breast cancer cells in a way that may contribute to 
hypoxia-induced invasive migration (  Yoon et al., 2005  ). These 
fi  ndings, in combination with the fact that the gene for RCP is 
located within a small amplicon (8p11-12) prevalent in breast 
cancer (  Gelsi-Boyer et al., 2005  ), led us to investigate a poten-
tial role for class I Rab11-FIPs in coordinating the traffi  cking of 
integrins and other proinvasive receptors as tumor cells migrate 
in 3D microenvironments in response to tumor-relevant chemo-
kinetic factors such as osteopontin and EGF. 
  Results 
  Inhibition of     v    3 promotes     5    1 recycling 
in A2780 cells 
  We have previously shown that perturbation of   “  short-loop  ”   
   v   3 recycling leads to a marked increase in    5  1  recycling 
(  White et al., 2007  ), so we sought to determine whether such 
reciprocative cross talk between these two integrins also occurs 
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analyzed the movement of A2780 cells as they migrated into 
scratch wounds. A2780 cells migrated persistently after wounding 
(Video 1, available at http://www.jcb.org/cgi/content/full/jcb
.200804140/DC1), but treatment with either cilengitide (Video 2) 
or osteopontin induced a signifi  cantly more rapid but less per-
sistent mode of migration, and    5   1 was required for the 
increase in speed (  Fig. 2 B  ). In the absence of cilengitide, ex-
pression of RCP 
621E   did not effect cell migration. However, 
RCP 
621E   (but not dominant-negative Rab11-FIP2 or Rip11) com-
pletely opposed the cilengitide- or osteopontin-driven increase 
in migration speed (  Fig. 2 B  ), such that in the combined pres-
ence of the cyclic peptide and dominant-negative RCP the cells 
appeared to wobble on the spot and were largely unable to move 
away from their original positions (Video 3). 
unable to drive   5  1 recycling after RCP knockdown or expression 
of dominant-negative RCP 
621E   ( Fig.  2  A ).  The  corresponding 
dominant-negative mutants of Rip11 or Rab11-FIP2 (Rip11 
630E  
and FIP2 
481E  ) had no effect on cilengitide-induced    5  1  recycling 
(Fig. S2 B), and RCP 
621E   did not compromise traffi  cking of the 
transferrin receptor (Tfn-R) in the presence or absence of cilen-
gitide (Fig. S2 C). Internalization of    5   1 was not affected by 
expression of dominant-negative RCP (Fig. S1 B). These data 
indicate that RCP displays selectivity toward the recycling of 
specifi  c cargoes (i.e.,    5   1 not Tfn-R) that follow Rab11-
dependent routes to the cell surface and that RCP is likely to be 
the only class I FIP that has a role in traffi  cking    5  1. 
  As increased    5   1 recycling causes fi  broblasts to switch 
from persistent to random migration (  White et al., 2007  ), we 
  Figure 1.       Inhibition of     v    3 promotes     5    1 
recycling and association of RCP with     5    1.   
(A) A2780 cells were transfected with a non-
targeting shRNA (sh-CON) or a short hairpin  –
  targeting     3 integrin (sh-    3; right) or were left 
untransfected (left). Cells were surface labeled 
with 0.2 mg/ml NHS-S-S-Biotin at 4  °  C and in-
ternalization was then allowed to proceed for 
30 min at 37  °  C. Biotin remaining at the cell 
surface was removed by exposure to MesNa 
at 4  °  C, and internalized integrin was chased 
back to the cell surface at 37  °  C for the indi-
cated times in the absence (BAS) or presence 
(CIL) of 1   μ  M cilengitide, 1   μ  M c-RADfV, 4.4   μ  M 
cRGDfV, or 0.5   μ  g/ml soluble osteopontin. 
Cells were then reexposed to MesNa and bio-
tinylated integrin was determined by capture 
ELISA using microtitre wells coated with anti-
human     5 integrin monoclonal antibodies. The 
proportion of integrin recycled to the plasma 
membrane is expressed as a percentage of the 
pool of integrin labeled during the internaliza-
tion period. (left) Values are mean   ±   SEM;   n   = 7 
(BAS),   n   = 4 (CIL), and   n   = 3 (cRADfV, cRGDfV, 
and OSP) independent experiments. (right) 
Values are mean   ±   SEM;   n   = 3 independent 
experiments. (B) A2780 cells were transfected 
with plasmids encoding GFP or GFP fused to 
the class I FIPs (GFP-RCP, GFP-FIP2, and GFP-
Rip11). Transfected cells were incubated in the 
absence (BAS) or presence (CIL) of 1   μ  M ci-
lengitide for 20 min and lysed in a buffer con-
taining 0.15% Tween-20. GFP and GFP fusion 
proteins were immunoprecipitated from lysates 
by incubation with beads coupled to a mono-
clonal antibody recognizing GFP, and these 
immunoprecipitates analyzed for the presence 
of     5    1 and     v    3 by immunoblotting with 
antibodies recognizing the integrin     5 and     3 
chains, respectively. The loading of GFP and 
GFP fusions was conﬁ  rmed by immunoblotting 
with an antibody recognizing GFP (bottom). 
(C) Cells were transfected with GFP-RCP (top) 
or left untransfected (bottom), and then incu-
bated in the absence (BAS) or presence (CIL) 
of 1   μ  M cilengitide for 20 min. Lysates were 
immunoprecipitated using monoclonal anti-
bodies recognizing     5    1 integrin (anti-    5), 
    v    3 integrin (anti-    3), or an isotype-matched 
control antibody (RG-16). The presence of     5 
and     3 integrin, GFP-RCP, and endogenous 
RCP were detected by immunoblotting. (D) After cotransfection of GFP or GFP-RCP with either nontargeting shRNA (shRNA-CON) or a short hairpin target-
ing     3 integrin (shRNA-    3), A2780 cells were incubated in the absence (BAS) or presence (CIL) of 1   μ  M cilengitide or 0.5   μ  g/ml osteopontin (OSP) for 
20 min. Cells were lysed and anti-GFP immunoprecipitates probed for the presence of     5    1 and GFP as in B. (E) A2780 cells were transfected with GFP, 
GFP-RCP 
wt  , or GFP-RCP 
621E  , treated with cilengitide, and then lysed. Anti-GFP immunoprecipitates were probed for     5    1 and GFP as in B.     JCB • VOLUME 183 • NUMBER 1 • 2008  146
FN inhibit invasive migration of Fos-transformed fi  broblasts 
through matrigel (  Spence et al., 2006  ). However, expression of 
Rab25 changes the way in which    5  1  is  traffi  cked such that 
   5   1 supports migration of Fos-transformed fi  broblasts through 
3D FN-containing matrices (  Caswell et al., 2007  ). We, therefore, 
sought to determine whether cilengitide-driven, RCP-dependent 
changes in    5  1  traffi  cking were suffi  cient to promote migra-
tion into 3D matrices. When    v   3 was not inhibited, migration 
of A2780 cells was unaffected by addition of FN to the matrigel 
(  Fig. 4 A  ). However, addition of cilengitide or osteopontin 
strongly promoted FN-dependent migration of A2780 cells into 
matrigel plugs (  Fig. 4 A  ). Experiments using blocking anti-
bodies and RNAi of integrin subunits indicated that this com-
ponent of migration was dependent on the presence and RGD 
ligand  –  binding capacity of    5   1 integrin (  Fig. 4 B  ). Depletion 
of     3 integrin with RNAi strongly promoted FN-dependent mi-
gration into matrigel (in the absence of FN,    3  knockdown  sup-
pressed migration), and neither cilengitide nor osteopontin were 
able to further increase this (  Fig. 4 A  ). Although basal migration 
of A2780 cells did not require RCP, the cilengitide-driven increase 
in migration through matrigel was suppressed by dominant-
negative RCP 
621E   or short hairpin RNA (shRNA) of RCP (  Fig. 4 C  ), 
but was not affected by the corresponding mutants of Rab11-FIP2 
or Rip11 (Fig. S5 A, available at http://www.jcb.org/cgi/content/
full/jcb.200804140/DC1). 
  To determine how cilengitide promotes cell migration in 
3D, while minimizing the technical diffi  culties in imaging cell 
migration within dense 3D microenvironments, we analyzed the 
migration of cells plated onto cell-derived matrix. We have previ-
ously found that expression of Rab25 induced A2780 cells to be 
more invasive and to switch their mode of migration to one that is 
  Fluorescence time-lapse imaging revealed that migrating 
A2780 cells adopted a fanlike morphology in which the actin-
rich lamellipodium advanced in an organized, processive fash-
ion, with retrograde movement of fi  laments back from the leading 
edge being clearly visible (Video 4, available at http://www.jcb
.org/cgi/content/full/jcb.200804140/DC1). Furthermore, 3D re-
construction of serial z stack confocal images indicated that the 
F-actin  –  rich lamellipodial tip of migrating A2780 cells did not 
rise much above the surface of the substratum (  Fig. 3 A  , left). 
However, upon challenge with cilengitide or osteopontin, or 
when    v   3 was suppressed by RNAi, the morphology of migrat-
ing A2780 cells was drastically altered, with an apparent collapse 
of the lamellipodium and the presence of anterior protrusions 
containing    5   1 integrin, RCP, and F-actin (Fig. S4). 3D recon-
structions indicated that these protrusions were composed of nu-
merous actin-rich ruffl  es that extended upward from the cell front 
(  Fig. 3 A  , middle and right). Fluorescence time-lapse imaging 
showed these cilengitide- and osteopontin-driven structures to 
be very actively protrusive and always anterior to the direction of 
migration (Videos 4  –  6), indicating that they were neither dorsal 
ruffl  es nor retracting lamellae, but likely locomoting structures 
contributing to the cell  ’  s forward motion. Moreover, expression 
of dominant-negative RCP (but not dominant-negative FIP2 or 
Rip11) blocked the ability of A2780 cells to extend these anterior 
ruffl  ing protrusions (  Fig. 3 B  ), indicating a requirement for RCP 
(but not other class I Rab11-FIPs) in this type of cell migration. 
  RCP and     5    1 promote ﬁ  bronectin (FN)-
dependent migration in 3D 
  The capacity of    5   1 to support migration in 3D matrices is 
dictated by the way in which it is traffi  cked. Indeed,    5  1  and 
  Figure 2.       Cilengitide and osteopontin drive 
alterations in     5    1 recycling and cell migra-
tion that are dependent on RCP.   (A) A2780 cells 
were transfected with a nontargeting shRNA 
(shRNA-CON), a short hairpin targeting RCP 
(shRNA-RCP), GFP-RCP 
wt  , or dominant-negative 
GFP-RCP 
621E  . Recycling of     5    1 integrin was 
determined in the presence and absence of 1   μ  M 
cilengitide as for   Fig. 1 A  . Values are mean   ±   
SEM;   n   = 3 independent experiments. (B) Cells 
were transfected with GFP-RCP 
wt   or GFP-RCP 
621E   
and allowed to grow to conﬂ  uence. Conﬂ  uent 
monolayers were wounded with a plastic pipette 
tip and the cells were allowed to migrate into 
the wound in the absence (Basal) or presence of 
1   μ  M cilengitide (Cil) or 0.5   μ  g/ml osteopontin 
(Osp). The cells were observed by time-lapse 
video microscopy, the movement of individual 
cells followed using cell tracking software, and 
this is presented as overlays of representative 
trajectories described by cells during the ﬁ  rst 
9 h of their migration into the wound. The starting 
position of each cell is denoted by the red dot. 
Examples of time-lapse movies that correspond 
to these experiments are included as Videos 
1  –  3 as indicated (available at http://www.jcb
.org/cgi/content/full/jcb.200804140/DC1). 
The persistence and speed of migration were 
extracted from the track plots. Persistence is de-
ﬁ  ned as the ratio of the vectorial distance trav-
eled to the total path length described by the 
cell. Values are mean   ±   SEM;   n   = 3 indepen-
dent experiments. Bar, 50   μ  m.     147 RCP,     5    1, EGFR1, AND MIGRATION   • Caswell et al. 
alters cellular morphology to favor rapid/random movement on 
plastic surfaces and a pseudopodial-driven mode of migration on 
a 3D matrix. 
  RCP-regulated recycling does not affect 
the ability of     5    1 to bind to FN 
  Regulation of integrin internalization and recycling may infl  u-
ence cell adhesion and migration by controlling the level of hetero-
dimer exposed at the plasma membrane. Addition of cilengitide 
and expression of mutant RCPs infl  uence the amount of    5  1 
expressed at the cell surface (Fig. S5 B), but do so only modestly 
and to a degree that is consistent with the way that they alter re-
cycling from a relatively small (    15  –  20% of the quantity of sur-
face receptor [not depicted]) intracellular pool of    5  1  integrin. 
We had, therefore, previously hypothesized that endosomal path-
ways may not function primarily to control the quantity of sur-
face receptors, but that they regulate integrin function in other 
ways, for example, by   “  cleaning  ”   internalized integrins of bound 
ligand, thus maintaining ligand-binding competency (  Caswell and 
Norman, 2006  ;   White et al., 2007  ). To analyze the effect of re-
cycling on integrin function we used a spinning disc approach, 
which measures the mean shear stress (    50  ) required for cell de-
tachment (  Garcia et al., 1998  ). Because     50   is proportional to the 
number of    5   1 and    v   3 integrins per cell that are occupied in 
adhesive bonds, this provides a direct measure of integrin adhesive 
characterized by the extension of long pseudopods (  Caswell 
et al., 2007  ). As previously observed, A2780 cells migrated rapidly 
across cell-derived matrices and maintained their overall sluglike 
morphology as they moved (  Fig. 5 A   and Video 7, available at 
http://www.jcb.org/cgi/content/full/jcb.200804140/DC1). Addi-
tion of cilengitide altered the morphology of cells migrating on 
3D matrices to extend long pseudopods in the direction of migra-
tion (  Fig. 5, A and B;   and Video 8). When    v   3 was not inhib-
ited, migration on cell-derived matrix had no requirement for 
RCP (  Fig. 5 A  ), but expression of RCP 
621E   completely abrogated 
cilengitide-driven pseudopodial extension and markedly decreased 
both the speed and persistence of cell movement (  Fig. 5, A and B  ; 
and Video 9). The dynamic localization of RCP within migrating 
cells was also strikingly altered by treatment with cilengitide. 
In untreated cells, GFP-RCP localized to the perinuclear region 
and to vesicles distributed fairly uniformly throughout the cyto-
plasm (  Fig. 5 C  ). However, after addition of cilengitide, GFP-
RCP (but not dominant-negative GFP-RCP 
621E  ) was recruited to 
the tip of the extending pseudopod (  Fig. 5 C  ). Although there was 
considerable movement of RCP-positive tubulovesicular struc-
tures in and out of the pseudopodial region, the RCP-containing 
structures at the distal pseudopod tip appeared to be relatively 
immobile and closely associated with the plasma membrane. 
Collectively, these data indicate that inhibition of    v  3  strongly 
promotes RCP-dependent traffi  cking of    5  1  integrin,  which 
  Figure 3.       Inhibition of     v    3 promotes the 
formation of dynamic actin-rich protrusions 
at the cell front.   (A) Conﬂ  uent  monolayers 
were wounded with a plastic pipette tip and 
the were cells allowed to migrate for 2 h into 
the wound in the absence (BASAL) or pres-
ence of 1   μ  M cilengitide (CIL) or 0.5   μ  g/ml 
osteopontin (OSP). Cells were ﬁ  xed  and 
permeabilized and F-actin was visualized us-
ing ﬂ   uorescently conjugated phalloidin. 3D 
reconstructions were generated from serial 
Z sections captured using a confocal micro-
scope. Yellow arrow denotes the direction of 
cell migration. Bar, 10   μ  m. Time-lapse movies 
indicating the dynamics of GFP-actin under 
conditions corresponding to the experiments 
presented in A are included as Videos 4  –  6, 
respectively (available at http://www.jcb
.org/cgi/content/full/jcb.200804140/DC1). 
(B) A2780 cells were transfected with GFP-RCP 
wt  , 
GFP-RCP 
621E  , GFP-FIP2 
480E  , or GFP-Rip11 
630E  . 
Conﬂ  uent monolayers were wounded with a 
plastic pipette tip and the cells were allowed 
to migrate for 2 h into the wound in the ab-
sence or presence of 1   μ  M cilengitide. Cells 
were ﬁ  xed and permeabilized and GFP and 
F-actin was visualized by ﬂ  uorescence micros-
copy. 3D reconstructions were generated from 
serial Z sections captured using a confocal mi-
croscope. Yellow arrow denotes the direction 
of cell migration. Bar, 10   μ  m.     JCB • VOLUME 183 • NUMBER 1 • 2008  148
  RCP associates with EGFR1 and     5    1 
to coordinate their recycling 
  As the endosomal pathway is known to have profound infl  uence 
on the way that many receptors communicate with their down-
stream effectors (  von Zastrow and Sorkin, 2007  ), it is possible 
that integrin recycling alters cell migration by infl  uencing the 
assembly of signalosomes that mediate receptor tyrosine kinase 
(RTK) signaling. To investigate this possibility we probed RCP 
immunoprecipitates with antibodies recognizing phosphotyro-
sine. Although cytoskeletal phosphotyrosine-containing proteins 
such as paxillin were not present in RCP immunoprecipitates 
(Fig. S3 B), we consistently observed a high molecular mass 
phosphotyrosine-rich band with the approximate molecular mass 
of EGFR1 (not depicted). Indeed, addition of cilengitide, osteo-
pontin, or RNAi of    3  drove    5   1 and EGFR1 into a coprecipi-
table complex with endogenous or overexpressed RCP ( Fig. 6 C ), 
and this correlated closely with recruitment of EGFR1 to F-actin  –
  rich protrusions at the cell front and its colocalization with RCP 
at these structures (  Fig. 6, D  –  F  ). Given this coprecipitation of 
function (  Boettiger et al., 2001  ;   Shi and Boettiger, 2003  ;   Boettiger, 
2007  ). The generation of     50   from curve fi  ts of the spinning data 
(  Fig. 6 A  ) was used to generate a comparison of integrin bond 
levels (  Fig. 6 B  ). Addition of cilengitide reduced the total adhe-
sion, as measured by the spinning disc, by     14% consistent with 
the contribution that is typically made to adhesion by    v  3  in 
cells expressing both    v  3  and    5   1. As shown in   Fig. 3 A  , in-
hibition of RCP reduces cilengitide-driven    5   1 recycling by at 
least threefold. Therefore, if recycling were to infl  uence    5  1 ’ s 
ligand-binding capacity, one would anticipate a large alteration in 
adhesion strength after inhibition of RCP. However, expression of 
RCP 
621E   effected only a small change (10  –  15% reduction) in ad-
hesion strength ( Fig. 6 B ), indicating that the quantity and strength 
of integrin  –  ligand adhesive bonds is proportional to the level of 
surface expression (Fig. S5 B) and not to the proportion of inte-
grin recycled. Because RCP does not infl  uence the ligand-binding 
capacity of    5   1, it is likely that there are alternative explanations 
for the ability of this type of recycling to promote cell migration 
and invasiveness. 
  Figure 4.       Inhibition of     v    3 promotes mi-
gration into matrigel that is dependent on 
RCP and engagement of     5    1 with FN.   
(A) Migration of A2780 cells expressing a 
nontar  geting shRNA (shRNA-Con) or a short 
hairpin targeting     3 integrin (shRNA-    3) into 
a matrigel plug in the presence and absence of 
25   μ  g/ml FN was determined using an inverted 
matrigel plug assay. 1   μ  M cilengitide (CIL) and 
0.5   μ  g/ml osteopontin (OSP) were added as 
indicated to the matrigel and to both the up-
per and lower chambers of the inverted matri-
gel plug assay. Invading cells were stained 
with Calcein AM and visualized by confocal 
microscopy. Serial optical sections were cap-
tured at 15-  μ  m intervals and are presented as 
a sequence in which the individual optical sec-
tions are placed alongside one another with 
increasing depth from left to right as indicated. 
Migration was quantitated by measuring the 
ﬂ   uorescence intensity of cells penetrating the 
matrigel to depths of 45   μ  m and greater and 
expressing this as a percentage of the total 
ﬂ   uorescence intensity of all cells within the 
plug. Data represents mean   ±   SEM from three 
independent experiments. (B) The involvement 
of     5    1 integrin in migration driven by addi-
tion of cilengitide (left and right) or induced by 
suppression of     v    3 levels (middle) was de-
termined by addition of the indicated integrin- 
and FN-blocking antibodies (left and middle) 
and also by RNAi of the     5 and     1 subunits of 
    5    1 (right). Migration was quantiﬁ  ed as for A. 
Values are mean   ±   SEM from three indepen-
dent experiments. (C) The migration of A2780 
cells expressing nontargeting shRNA (shRNA-
CON), a short hairpin targeting RCP integrin 
(shRNA-RCP), GFP, GFP-RCP 
wt  , or GFP-RCP 
621E   
into FN-containing matrigel was determined 
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   5   1 with RCP and EGFR1, we sought to determine whether 
RCP was acting as a molecular bridge to connect    5  1  and 
EGFR1. First, we found that    5-RNAi  prevented  coprecipitation 
of EGFR1 with RCP, whereas EGFR1-RNAi did not reduce as-
sociation of RCP with    5   1 (  Fig. 6 C  ). Second, we deployed the 
mutant RCP 
379-649   that lacks an N-terminal portion of the protein, 
including the C2 domain, but retains the C terminus and Rab11-
binding domain. Interestingly, this truncated RCP associated with 
   5   1 integrin but had no capacity to coprecipitate with EGFR1 
(  Fig. 6 C  ). Furthermore, dominant-negative RCP 
621E   did  not 
coprecipitate with either     5 or EGFR1 (  Fig. 6 C  ) and RNAi of 
RCP prevented coprecipitation of EGFR1 with    5   1 (not de-
picted). Collectively, these data indicate that the C terminus of 
RCP interacts with    5   1 to permit an association between the 
N terminus of RCP with EGFR1, thus bringing these two recep-
tors together into a coprecipitable complex. 
  The presence of such a physical association between    5  1, 
RCP, and EGFR1 prompted us to investigate the role of RCP 
in coordination of    5   1 and EGFR1 traffi  cking. Cilengitide, 
osteopontin, cRGDfV, and     3-RNAi promoted EGFR1 recycling 
to a similar extent as was previously observed for    5  1,  and 
knockdown of RCP prevented this (  Fig. 7 A  ). Furthermore, ad-
dition of cilengitide and/or expression of dominant-negative 
RCP did not affect internalization of EGFR1 by A2780 cells 
(Fig. S1 B). Suppression of     5 integrin by RNAi blocked the 
cilengitide-induced increase in EGFR1 recycling, whereas knock-
down of EGFR1 had no effect on recycling of    5  1  ( Fig.  7  B ). 
Furthermore, expression of RCP 
379-649  (which can associate with 
   5   1 but not EGFR1) had minimal effect on cilengitide-driven 
   5   1 recycling, but severely impaired EGFR1 recycling (  Fig. 7 C  ). 
Collectively, these data indicate that cilengitide-driven recycling 
of EGFR1 is strongly dependent on    5   1 (but not vice versa) 
and that effective recycling of EGFR1 requires its association 
with RCP. 
  Expression of RCP 
379-649   opposes 
cilengitide-driven migration into 
FN-containing matrigel 
  EGFR1-RNAi inhibited the ability of A2780 cells to migrate into 
matrigel under all circumstances investigated (unpublished data), 
indicating a requirement for EGFR1 in the invasive process. 
To determine the role of traffi  cking to EGFR1  ’  s contribution to 
migration in 3D, we investigated the consequences of expressing 
RCP 
379-649   (which has little effect on    5   1 recycling but compro-
mises traffi  cking of EGFR1) on the ability of cilengitide to drive 
movement of cells into matrigel. Expression of RCP 
379-649   did not 
affect the basal migration of A2780 cells but inhibited the ability 
of cilengitide to drive cells into FN-containing matrix (  Fig. 7 D  ). 
Moreover, although GFP-RCP 
379-649   was localized to vesicular 
structures toward the cell front (indicating that integrin binding 
mediates the recruitment of RCP to extending processes), this 
  Figure 5.       Cilengitide drives RCP to the tips of extending pseudopods.   
(A and B) Cells were transfected with GFP-RCP 
wt   or GFP-RCP 
621E   and plated 
onto cell-derived matrix in the presence and absence of 1   μ  M cilengit-
ide     4 h before time-lapse microscopy. Images were captured every 
5 min over a 6-h period and movies were generated from these (Videos 
7  –  9) and stills from these movies are presented. Bar, 100   μ  m. (B) Speed 
and persistence of migration were determined as for   Fig. 3 B  , values are 
mean   ±   SEM;   n   = 3 independent experiments. To obtain a measure of 
pseudopod length, the distance between the center of the nucleus and the 
cell front (with respect to the direction of migration) was measured using 
ImageJ. Data represents mean   ±   SEM;   n   = 3 independent experiments. 
(C) Cells were transfected with GFP-RCP, GFP-RCP 
621E  , or GFP-RCP 
379-649   
and plated onto cell-derived matrix in the presence and absence of 1   μ  M 
cilengitide and imaged by confocal microscopy. Images were captured 
at 1 frame/second over a period of 100 s and movies were generated 
 
from these. Single section confocal image stills corresponding to individual 
frames from these movies are presented. Bar, 20   μ  m. The yellow arrows in-
dicate the direction of migration and the portion of the cell within the white 
square is presented as Video 10. Videos are available at http://www.jcb
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levels (  Fig. 8, A and B  ). Because osteopontin or cilengitide-
driven EGFR1 recycling required    5   1 and the association of 
EGFR1 with RCP, we investigated the involvement of    5  and 
RCP in EGFR1 signaling. Either RCP- or    5-RNAi  or  expression 
of RCP 
379-649   blocked the ability of osteopontin to potentiate 
EGF-driven EGFR1 autophosphorylation and activation of PKB/
Akt (  Fig. 8 C  ). Collectively, these data indicate that after in-
hibition of   v  3-mediated cell adhesion, EGFR1 was recruited 
into a physical complex with    5   1 and RCP, which enhances 
EGFR1 recycling to the plasma membrane and its ability to auto-
phosphorylate and to signal via PKB/Akt. 
  Discussion 
  Fibroblasts and some tumor cells can move upon plastic or glass 
substrates in different ways (  Pankov et al., 2005  ). Cells can 
migrate with persistence, allowing their translocation for con-
siderable distances from the starting point. Alternatively, some 
truncated RCP caused pseudopod bifurcation, suggesting that com-
bined recruitment of EGFR1 and    5   1 is necessary for mainte-
nance of pseudopodial dominance, which is in turn required for 
cilengitide-driven migration in 3D (  Fig. 5 C  ). 
      v    3  ’  s modulation of EGFR1 signaling 
proceeds via RCP and     5    1 
  Cilengitide addition and expression of dominant-negative RCP 
does not greatly affect the exposure of EGFR1 at the cell sur-
face (Fig. S5 B). However, the way in which receptors are traf-
fi  cked is now established to modulate the downstream signaling 
profi  le of several RTKs (  von Zastrow and Sorkin, 2007  ). Indeed, 
we found that pretreatment of A2780 cells with osteopontin or 
cilengitide or   3-RNAi (all of which enhance EGFR1 recycling) 
strongly potentiated the ability of EGF to drive EGFR1 auto-
phosphorylation (  Fig. 8, A and B  ). Pretreatment of cells with 
either osteopontin or cilengitide enhanced downstream signals 
to PKB/Akt but phosphorylation of ERK1/2 remained at basal 
  Figure 6.       RCP does not affect integrin li-
gand-binding ability but mediates an asso-
ciation between     5    1 and EGFR1.   (A and B) 
A2780 cells were transfected with either 
RCP 
wt   or the dominant-negative RCP 
621E   and 
incubated for 24 h   ±  1   μ  M cilengitide for the 
last 16 h. Adhesion to FN was analyzed us-
ing the spinning disc. (A) The analysis of cell 
density at 61 points for each treatment as a 
function of wall shear stress (      50  ) is shown. The 
associated curve ﬁ  t (solid lines) R 
2   values for 
the ﬁ  ts are 0.95 (RCP 
wt   with cilengitide) and 
0.92 (RCP 
621E   with cilengitide). The curve ﬁ  ts 
were used to extract a mean shear stress for 
cell detachment (      50  ) that is proportional to 
the number of adhesive integrin  –  ligand bonds 
(  Boettiger, 2007  ). (B) The combined analyses 
for       50   from three independent experiments 
run in triplicate are shown; normalized per-
centages are on the bars. Values are mean   ±   
SEM (  n   = 8 or 9). (C) Cells were transfected 
with hairpin vectors targeting     3 integrin,     5 
integrin, or EGFR1 in combination with GFP, 
GFP-RCP 
wt  , or GFP-RCP 
621E   (left), or were left 
untransfected (right). After incubation with 
1   μ  M cilengitide (CIL) or 0.5   μ  g/ml osteo-
pontin (OSP), cells were lysed and GFP-RCP or 
    5    1 was immunoprecipitated from the lysates 
using monoclonal antibodies recognizing GFP 
(anti-GFP),     5 integrin (anti-    5), or an isotype-
matched control antibody (RG-16). The pres-
ence of     5 integrin, GFP-RCP, endogenous RCP, 
and EGFR1 in the immunoprecipitates was 
then detected by immunoblotting. (D  –  F) A2780 
cells were transfected with a short hairpin  – 
targeting     3 integrin (shRNA-    3; F) or were 
left untransfected (D and E). Conﬂ  uent mono-
layers were wounded and the cells were al-
lowed to migrate into the wound in the absence 
(D and F) or presence (E) of 1   μ  M cilengitide. 
The distribution of EGFR1 (green), RCP (red), 
and F-actin (blue) was visualized by immuno-
ﬂ  uorescence followed by confocal microscopy. 
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to increased migration into a FN-rich 3D gel. Moreover, this 
type of cell movement was characterized by the extension of 
long pseudopods at the cell front as cells migrate on a 3D ma-
trix, and RCP was concentrated at the tips of these invasive 
structures. This implies that    5   1 functions to promote tumor 
cell invasion and metastasis in vivo, with    v   3 acting to re-
strain this. 
  The role of integrin recycling in this switching between 
   v   3- and    5   1-mediated migration suggested that the re-
cycling process itself was affecting integrin function. Although 
differences in the total levels of surface integrin could not ex-
plain the differences, it was possible that integrins required 
recycling to reactivate or to remove bound ligand fragments 
(  Caswell and Norman, 2006  ). To test this hypothesis, we have 
measured the effect of cilengitide-induced recycling of    5  1 
integrin (and its inhibition by dominant-negative RCP) on    5  1 
surface expression and its ability to form adhesive bonds with 
substrate FN. The formation and the strength of the adhesive 
bonds was affected only to the extent expected for the contribu-
tions of    v   3 and the small reduction of surface    5  1  levels 
caused by inhibition of recycling. Unlike the common static 
adhesion assays, this assay measures the force required for cell 
cells move rapidly but with low persistence, thus remaining 
nearer their starting point. Previous analyses have shown that 
persistent migration occurs on FN substrates when    v  3  is 
the dominant integrin, but when    5   1 dominates cells move 
more rapidly but with reduced persistence (  Danen et al., 2005  ). 
We have shown that alterations in the relative rates at which 
   v   3 and    5  1  traffi  c through the endosomal pathway can switch 
between slow/persistent and rapid/random migration in fi  bro-
blasts (  White et al., 2007  ). When    v   3 is cycling rapidly and is 
competent to engage ligand, the recycling of    5   1 is slow and 
cells migrate persistently. Alternatively, when    v  3  traffi  cking 
is disrupted,    5   1 recycling is increased and this reduces mi-
grational persistence. Here, we report that treatment of tumor 
cells with endogenous (soluble osteopontin) and pharmacologi-
cal (cilengitide and c-RGDfV) antagonists of    v  3  increases 
the rate at which    5   1 is transported from endosomes to the 
plasma membrane. This increased recycling requires the associ-
ation of RCP with    5   1 and thus this Rab11 effector represents 
a key component of an integrin cross talk system that controls a 
switch between    v   3- and    5   1-mediated migrational modes. 
Remarkably, we fi  nd that although    5   1-driven migration has 
little persistence on plastic or glass surfaces (2D), it corresponds 
  Figure 7.           5    1 is required for recycling of 
EGFR1; and uncoupling EGFR1 recycling from 
    5    1 inhibits migration in 3D.   (A  –  C) Cells 
were transfected with short hairpin vectors 
targeting     3,     5,     1, RCP, or EGFR1 or with 
truncated GFP-RCP 
379-649   as indicated. The re-
ceptor recycling protocol was then followed as 
for   Fig. 1 A   but with biotinylated EGFR1 or 
    5    1 integrin being determined by capture 
ELISA using microtitre wells coated with anti-
EGFR1 or     5 integrin monoclonal antibod-
ies as indicated by the y-axis labeling of the 
graphs. The proportion of EGFR1 or integrin 
recycled to the plasma membrane is expressed 
as a percentage of the pool of integrin labeled 
during the internalization period. Values are 
mean   ±   SEM;   n   = 3 or 4 independent experi-
ments. (D) Migration of A2780 cells express-
ing GFP, GFP-RCP 
wt  , or GFP-RCP 
379-649   into 
matrigel plugs containing 25   μ  g/ml FN. 1   μ  M 
cilengitide (CIL) was added as indicated to 
the matrigel and to both the upper and lower 
chambers of the inverted invasion assay. 
Migrating cells were detected and quantiﬁ  ed 
as for   Fig. 4  . Values are mean   ±   SEM for three 
independent experiments.     JCB • VOLUME 183 • NUMBER 1 • 2008  152
this Rab effector to a membrane subdomain, whereupon a sec-
ondary association with EGFR1 is formed. 
 Effi  cient signaling from EGFR1 to the Ras  –  MEK  –  ERK 
axis requires receptor internalization, and a close association 
between EGFR1 and components of the MAPK cascade has 
been observed to occur at late endosomes (  von Zastrow and 
Sorkin, 2007  ). Conversely, it appears that EGFR1-stimulated 
activation of phosphoinositide-3 kinase most likely occurs at or 
near the plasma membrane and that communication between 
EGFR1 and PKB/Akt is terminated after receptor endocytosis 
(  Haugh and Meyer, 2002  ). In view of this, we propose that 
RCP-dependent recycling acts to slow the rate at which EGFR1 
reaches later endosomes where sustained activation of MAPKs 
occurs and favors its localization to the plasma membrane or 
recycling compartments where the receptor can recruit phos-
phoinositide-3 kinase and thereby activate PKB/Akt. Indeed a 
recent study has found that c-Src promotes the traffi  cking of 
FGF receptor from endosomes to the plasma membrane and 
that this favors activation of PKB/Akt over signaling to the 
MEK  –  ERK axis (  Sandilands et al., 2007  ). We fi  nd that c-Src 
binds to RCP and that this kinase is required for integrin and 
RTK recycling (unpublished data). Osteopontin enhances EGFR1 
signaling in a way that involves c-Src (  Das et al., 2004  ), which in 
light of the data presented here is likely to be mediated by RCP-
dependent effects on    5   1 and EGFR1 traffi  cking. Furthermore, 
detachment, which is directly proportional to the number of ad-
hesive integrin bonds ( Shi and Boettiger, 2003 ;  Boettiger, 2007 ). 
Therefore, recycling had no effect on ligand binding and adhe-
sive function of    5  1  integrin. 
  The absence of an effect of traffi  cking on integrin adhe-
sive function led us to examine the infl  uence of    5  1  recycling 
on cell signaling. Studies on tumor angiogenesis in mice show 
clearly that knockout of     3 leads to increased endothelial cell 
proliferation and migration owing to increased VEGFR2 sig-
naling (  Reynolds et al., 2004  ). Other studies have described 
physical complexes formed by integrins and RTKs, but the way 
in which these associations may regulate signaling is not clear 
(  Schneller et al., 1997  ;   Soldi et al., 1999  ). Here we have found 
that RCP is required to bring    5   1 and EGFR1 together into a 
physical complex and, although our results do not resolve all of 
the details of the RCP –   5  1 – EGFR1 complex (such as whether 
these associations involve direct molecular contacts between 
   5   1 and RCP and EGFR1 and RCP, respectively), we have 
determined how the traffi  cking of EGFR1 is coordinated with 
   5   1. Clearly knockdown of    5   1 opposes the coprecipita-
tion of RCP with EGFR1, indicating that recruitment of RCP  ’  s 
C-terminal region to    5   1 may likely be a prerequisite for sub-
sequent association of the N terminus of RCP with EGFR1 and 
for subsequent enhanced EGFR1 recycling. In this regard, it is 
possible that    5   1 is acting as a   “  receptor  ”   for RCP to guide 
  Figure 8.       Osteopontin enhances EGFR1 signaling via a mechanism that requires     5    1, RCP, and association of EGFR1 with RCP.   Cells were transfected 
with short hairpin vectors targeting     3,     5,     1, RCP or EGFR1 or with truncated GFP-RCP 
379-649   as indicated. Cells were serum starved overnight followed 
by a 40-min treatment with either 1   μ  M cilengitide or 0.5   μ  g/ml osteopontin. The cells were then challenged with EGF for the indicated times and lysed. 
Levels of active phosphoTyr 
845  -EGFR1, phosphoSer 
473  -Akt, and phosphoThr 
202  /phosphoTyr 
204  -ERK were determined by Western blotting. Protein loading of 
    -actin, Akt1, and EGFR1 was conﬁ  rmed by Western blotting.     153 RCP,     5    1, EGFR1, AND MIGRATION   • Caswell et al. 
three times through a 27-gauge needle and clariﬁ  ed by centrifugation at 
10,000   g   for 10 min at 4  °  C. Magnetic beads conjugated to sheep anti  –
  mouse IgG (Invitrogen) were bound to anti-integrin (anti-    5 or anti-    3; BD 
Biosciences), anti-GFP (Abcam), or control monoclonal (RG-16; Sigma-
Aldrich) antibodies. Antibody-coated beads were incubated with lysates 
for 2 h at 4  °  C with constant rotation. Unbound proteins were removed by 
extensive washing in lysis buffer, and speciﬁ  cally associated proteins were 
eluted from the beads by boiling for 10 min in Laemmli sample buffer. Pro-
teins were resolved by SDS-PAGE and analyzed by Western blotting as 
described previously (  Roberts et al., 2001  ). Antibodies used for Western 
blotting were as follows: anti-    5 integrin (BD Biosciences), anti-    1 integrin 
(BD Biosciences), anti-    3 integrin (BD Biosciences; blots using this antibody 
were run under nonreducing conditions), anti-RCP (Genway), anti-EGFR1 
(BD Biosciences) and anti-GFP (Abcam). 
  Inverted matrigel plug assay 
  Inverted matrigel assays were performed as described previously (  Hennigan 
et al., 1994  ). In brief, matrigel supplemented with 25   μ  g/ml FN as indi-
cated was allowed to polymerize in transwell inserts (Corning) for 1 h at 
37  °  C. Inserts were then inverted and cells were seeded directly onto the 
opposite face of the ﬁ  lter. Transwell inserts were ﬁ  nally placed in serum-
free medium, and medium supplemented with 10% FCS and 30 ng/ml 
EGF was placed on top of the matrix, providing a chemotactic gradient. 
Where appropriate, 1   μ  M cilengitide, 0.5   μ  g/ml osteopontin, and 1.0   μ  g/ml 
of integrin/FN-blocking antibodies were added to the matrigel before 
plug polymerization and also to the medium throughout the system. 48 h 
after seeding, migrating cells were stained with Calcein AM and visual-
ized by confocal microscopy with serial optical sections being captured at 
15-  μ  m intervals. 
  Generation of cell-derived matrix 
  Cell-derived matrix was generated as described previously (  Cukierman 
et al., 2001  ;   Bass et al., 2007  ). In brief, gelatin-coated tissue culture-ware 
was cross-linked with glutaraldehyde, quenched, and equilibrated in DME 
containing 10% FCS. Primary cultured human dermal ﬁ  broblasts were 
seeded at near conﬂ  uence (    2   ×   10 
4   cells/cm 
2  ) and grown for 10 d in 
DME containing 10% FCS and 50   μ  g/ml ascorbic acid. Matrices were de-
nuded of living cells by incubation with PBS containing 20 mM NH  4  OH 
and 0.5% Triton X-100, and DNA residue was removed by incubation with 
DNaseI. Matrices were blocked with 0.1% heat-denatured BSA before 
seeding of cells. 
  Receptor internalization and recycling assays 
  Internalization and recycling assays were performed after 30  –  45 min of 
serum starvation and subsequently conducted, including the internalization 
and recycling periods, in the absence of serum. Integrin and EGFR1 inter-
nalization and recycling assays were performed as described previously 
(  Roberts et al., 2001  ). Internalization assays were performed in the pres-
ence of 0.6 mM of primaquine as described in   Roberts et al. (2001)  . 
For measurement of recycling, the receptor internalization conditions were 
30 min at 37  °  C for all experiments. The antibodies used for capture ELISA 
detection of     5    1 integrin and EGFR1 were obtained from BD Biosciences. 
Cilengitide, osteopontin, cRADfV, and cRGDfV were added to the cells only 
during the recycling period. 
   
125  I-labeled transferrin recycling assays were performed essentially 
as described in   van Dam and Stoorvogel (2002)   with some modiﬁ  cations. 
In brief, serum-starved cells were incubated with  
125  I-labeled transferrin 
(0.1   μ  Ci/well; PerkinElmer) for 1 h at 4  °  C in PBS with 1% (wt/vol) BSA. 
The tracer was allowed to internalize for 30 min at 37  °  C (to label the re-
cycling compartment). Tracer remaining at the cell surface was removed by 
incubation with acid PBS (corrected to pH 4.0 by the addition of HCl) at 
4  °  C for 6 min, and the tracer was allowed to recycle at 37  °  C in serum-free 
DME supplemented with 1% BSA and 50   μ  M desferoxamine (Sigma-Aldrich). 
The quantity of  
125  I recycled into the medium is expressed as a percentage 
of the number of counts incorporated during the internalization period. 
  Microscopy, track-plot analysis, and 3D reconstruction 
  Conﬂ  uent monolayers were wounded with a plastic pipette tip and placed 
on the stage of an inverted microscope (Axiovert S100; Carl Zeiss, Inc.) in 
an atmosphere of 5% CO  2   at 37  °  C. Cells were observed using a 20  ×   
phase-contrast objective and images were collected every 20 min using a 
digital camera (C4742-95; Hamamatsu Photonics). Movies were gener-
ated and cell tracks were analyzed using Bioimaging software (Andor). 
For ﬂ  uorescence time-lapse imaging, cells were plated onto 6-well plates or 
glass-bottomed 3-cm plates (coated with cell-derived matrix as appropriate) 
we fi  nd that RTK recycling and signaling is infl  uenced by 
RCP/   5  1 in other cell types, including VEGFR2 in endothelial 
cells and FGF receptor in fi  broblasts (unpublished data). It is 
interesting to note that the genes for RCP and FGF receptor 1 
are located close to one another within the 8p11-12 chromo-
somal region that is amplified in several cancers, including 
some breast tumors (  Gelsi-Boyer et al., 2005  ). In this regard, 
it will be necessary to determine the molecular details of this 
apparently promiscuous association of RTKs with the RCP  –
   5   1 complex and how this infl  uences their traffi  cking and sig-
naling in cancer types where the 8p11-12 chromosomal locus 
is amplifi  ed. 
  In phase I and II clinical trails cilengitide has elicited some 
enduring responses in glioma patients (  Nabors et al., 2007  ), but 
the results for other types of cancer are not encouraging (  Friess 
et al., 2006  ;   Hariharan et al., 2007  ). Indeed, the role that    v  3 
plays in cancer-relevant processes is controversial, as some 
studies implicate    v   3 as a proangiogenic integrin (  Brooks 
et al., 1994  ), whereas other work contradicts this (  Reynolds 
et al., 2002  ). Our fi  ndings support both pro- and antiinvasive 
roles for    v   3, as knockdown of    v   3 can reduce A2780 cell 
migration but only in the absence of FN or when RCP-dependent 
processes are compromised. Conversely, when FN is abundant 
and    5   1 and RCP are present (as is the case in many tumor 
types), inhibition of    v   3 strongly promotes tumor cell migra-
tion, thus overriding the capacity for this integrin to function as 
an antimigratory molecule. We consistently fi  nd that cellular 
responses to cilengitide, c-RGDfV, small molecule inhibitors of 
   v   3 (unpublished data), and osteopontin are indistinguishable 
from one another (and from     3 knockdown), indicating the pos-
sibility that the lack of effi  cacy of anti-   v   3 compounds in can-
cer may be owing to the capacity of these molecules to mimic 
the prometastatic effects of osteopontin. 
 In conclusion, our surprising fi  nding that inhibition of   v  3 
leads to increased tumor cell migration in 3D microenvironments, 
and the elucidation of the RCP  –     5  1 – EGFR1 – dependent  mech-
anisms that drive this, highlight the need to fully understand how 
integrin traffi  cking regulates cell migration if the therapeutic 
potential of anti-integrin agents is to be maximized. 
  Materials and methods 
  Cell culture and transfection 
  A2780 cells were maintained in RPMI supplemented with 10% (vol/vol) 
serum at 37  °  C and 10% CO  2  . All constructs, shRNAi vectors, and RNAi 
oligonucleotides were transfected into cells using the Nucleofector system 
(solution T, program A-23; Amaxa) according to the manufacturer  ’  s in-
structions. All plasmids were puriﬁ  ed by CsCl banding before transfec-
tion by nucleofection. 
  Plasmid constructs 
  The Rab11-FIP constructs have been previously described as follows: 
pEGFP-C3 RCP and pEGFP-C1 RCP 
379-649   in   Damiani et al. (2004)  ; pEGFP-
C1 FIP2 in   Lindsay and McCaffrey (2002)  ; pEGFP-C1 Rip11, pEGFP-C1 
Rip11 
630E  , pEGFP-C3 RCP 
621E  , and pEGFP-C1 FIP2 
481E   in   Lindsay and 
McCaffrey (2004b)  . 
  Immunoprecipitation and Western blotting 
  A2780 cells were lysed in lysis buffer (200 mM NaCl, 75 mM Tris-HCl, 
pH 7, 15 mM NaF, 1.5 mM Na  3  VO  4  , 7.5 mM EDTA, 7.5 mM EGTA, 
0.15% (vol/vol) Tween-20, 50   μ  g/ml leupeptin, 50   μ  g/ml aprotinin, and 
1 mM 4-(2-aminoethyl)-benzenesulfonyl ﬂ  uoride). Lysates were passed JCB • VOLUME 183 • NUMBER 1 • 2008  154
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and incubated at 37  °  C until cells adhered and began migrating (4 h). Cells 
were imaged using a 10  ×   objective and an inverted microscope in an at-
mosphere of 5% CO  2   at 37  °  C or a 64  ×   objective and an inverted confocal 
microscope (Fluoview FV1000; Olympus) in an atmosphere of 5% CO  2   at 
37  °  C. For immunoﬂ  uorescence, cell were ﬁ  xed in 4% paraformaldehyde 
for 10 min and then permeabilized in PBS containing 0.2% Triton X-100. 
Primary antibodies for immunoﬂ   uorescence were     5 integrin (BD Biosci-
ences), RCP (Genway), and EGFR1 (BD Biosciences) with F-actin being de-
tected using BODIPY  650/665  -phalloidin (Invitrogen). Immunoﬂ  uorescence 
was imaged using a 64  ×   objective and an inverted confocal microscope. 
Images from the confocal microscope were imported into Photoshop 
(Adobe) and linear-only adjustments made to their brightness and contrast. 
  To generate 3D reconstructions, serial z-stack images were captured 
using a 64  ×   objective and an inverted confocal microscope and imported 
into Volocity Visualization (Improvision). Individual cells were cropped in 
the XY plane from ﬁ  elds of view containing more than one cell. HR opacity 
rendering was used to create a 3D image, which was rotated along the 
x axis to create XZ, XZ, and XYZ projections. 
  Assessment of EGF signaling 
  Cells were serum starved overnight. On the day of the experiment, cells 
were treated with either 1   μ  M cilengitide or 0.5   μ  g/ml osteopontin for 
40 min, immediately before a challenge with 30 ng/ml EGF (Sigma-Aldrich) 
for 5 or 10 min as indicated. Western blotting was then used to determine 
levels of active signaling moieties using the following antibodies: anti  – 
phosphoTyr 
845    –  EGFR1 (Cell Signaling Technology), anti  –  phosphoSer 
473    –  Akt 
(Cell Signaling Technology), and anti  –  phosphoThr 
202  /phosphoTyr 
204    –  ERK 
(Cell Signaling Technology). The following antibodies were used to assess 
protein loading: anti-EGFR1 (BD Biosciences), anti-Akt1 (Cell Signaling 
Technology), and     -actin (Sigma-Aldrich). 
  Spinning disc methods 
  A2780 cells transfected with RCP 
wt   or RCP 
621E   were plated overnight in 
complete medium   ±   1   μ  M cilengitide for the last 16 h. Cells were dissoci-
ated with 2 mM EDTA and single cell suspensions were added to FN-coated 
(5   μ  g/ml) glass coverslips and incubated at 25  °  C for 60 min. Coverslips 
were placed on the spinning disc device and exposed to a linear hydro-
dynamic shear gradient for 5 min (  Boettiger, 2007  ). Coverslips were re-
moved from the spinning device, ﬁ  xed in formalin, permeabilized, and stained 
with DAPI. 61 ﬁ  elds at 15 different radial positions plus the center were 
counted for 1-  μ  m-diameter ﬁ  elds and plotted as a function of shear stress. 
Curve ﬁ  ts were performed using SigmaPlot 7.0 using the formula f = 
1/  {  a      exp[b (t      c)]  }  , where f is the fraction of adherent cells, t is the 
cor  responding shear stress, and a, b, and c are ﬁ  t parameters; c is the 
shear stress for 50% detachment. 
  Online supplemental material 
  Fig. S1 A displays Western blots indicating the efﬁ  cacy of shRNA vectors 
targeting     3 and     5 integrins, EGFR1, and RCP. Fig. S1 B shows results 
from internalization assays indicating that addition of cilengitide and ex-
pression of dominant-negative RCP 
621E   do not greatly inﬂ  uence the con-
stitutive endocytosis of     5    1 or EGFR1. Fig. S2 indicates the inability of 
dominant-negative Rab11 
124I  , Rip11 
630E  , FIP2 
480E  , and RCP 
621E   to inﬂ  uence 
recycling of     5    1 integrin and Tfn-R. Fig. S3 shows the time course over 
which physical association of GFP-RCP and     5    1 integrin is established 
after the addition of cilengitide and shows the lack of coprecipitation of 
paxillin with GFP-RCP. Fig. S4 shows confocal immunoﬂ  uorescence images 
illustrating the inﬂ  uence of cilengitide/osteopontin or knockdown of     3 
integrin on cellular morphology and the distribution of     5    1 and RCP. 
Fig. S5 shows data indicating that dominant-negative Rip11 
630E   and FIP2 
480E   
do not inﬂ  uence migration through FN-containing matrigel, and Fig. S5 B 
documents the consequences of expression of dominant-negative RCP 
621E   
and/or addition of cilengitide on     5    1 and EGFR1 surface expression. 
Videos 1  –  3 show that addition of cilengitide promotes a rapid/random 
mode of cell migration on 2D surfaces that is opposed by expression of 
dominant-negative RCP 
621E  . Videos 4  –  6 show that whereas A2780 cells 
expressing GFP-actin extend an organized fan-like lamellipodium as they 
move, after treatment with cilengitide or osteopontin their movement is 
characterized by the formation of highly dynamic actin-rich protrusions at 
the cell front. Videos 7  –  9 show that cilengitide promotes a pseudopodial 
mode of cell migration on cell-derived matrix that is opposed by expression 
of RCP 
621E  . Video 10 is a high-resolution ﬂ  uorescence time-lapse sequence 
showing GFP-RCP localization to the tip of the extending pseudopod as 
A2780 cells migrate on a 3D matrix. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200804140/DC1. 155 RCP,     5    1, EGFR1, AND MIGRATION   • Caswell et al. 
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